Christopher Posner Cara Therapeutics, Inc. (CARA) insider trading activity
Christopher Posner is PRESIDENT AND CEO of Cara Therapeutics, Inc.. Currently has a direct ownership of 176,585 shares of CARA, which is worth approximately $45,912. The most recent transaction as insider was on May 02, 2024, when has been sold 3,936 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $2,952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
177K
2.18%
3M change
2.36%
12M change
Total Value Held
$45,912
Christopher Posner Transaction History
CP
Christopher Posner
PRESIDENT AND CEO
Stamford, CT